Rockefeller Capital Management L.P. Zai Lab LTD Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$34.2 - $51.69 $820 - $1,240	-24 Reduced 82.76%	5 $0
Q2 2022 Aug 12, 2022	SELL	$23.14 - $49.68 $370 - $794	-16 Reduced 35.56%	29 $1,000
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $1,249 - $2,898	45 New	45 $1,000
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $525 - $891	-5 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$125.11 - $180.0 $95,584 - $137,520	-764 Reduced 99.35%	5 $0
Q1 2021 May 11, 2021	BUY	$126.27 - $191.71 $97,101 - $147,424	769 New	769 $102,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.